Ovarian Cancer Immunotherapy: Turning up the Heat

Epithelial ovarian cancer (EOC) is the leading cause of death among gynecological malignancies. Despite surgery and chemotherapy, 5-years survival rates have improved only modestly over the past few decades remaining at 45% for advanced stages. Therefore, novel therapies are urgently needed. The pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghisoni, Eleonora, Imbimbo, Martina, Zimmermann, Stefan, Valabrega, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628106/
https://www.ncbi.nlm.nih.gov/pubmed/31208030
http://dx.doi.org/10.3390/ijms20122927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628106/
https://www.ncbi.nlm.nih.gov/pubmed/31208030
http://dx.doi.org/10.3390/ijms20122927

Ejemplares similares